Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference58 articles.
1. Scott J, Poffenbarger PL: Pharmacogenetics of tolbutamide metabolism in humans. Diabetes 1979, 28:41–51.
2. Relling MV, Aoyama T, Gonzalez FJ, Meyer UA: Tolbutamide and mephenytoin hydroxylation by human cytochrome P450s in the CYP2C subfamily. J Pharmacol Exp Ther 1990, 252:442–447.
3. Kirchheiner J, Brockmoller J, Meineke I, et al.: Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers. Clin Pharmacol Ther 2002, 71:286–296.
4. Elliot DJ, Suharjono, Lewis BC, et al.: Identification of the human cytochromes P450 catalysing the rate-limiting pathways of gliclazide elimination. Br J Clin Pharmacol 2007, 64:450–457.
5. Kidd RS, Curry TB, Gallagher S, et al.: Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin. Pharmacogenetics 2001, 11:803–808.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献